Skip to main content

Advertisement

SpringerLink
Log in

Letter to the editors of the Journal of Cancer Research and Clinical Oncology

  • Letter to the Editor
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Deeks JJ, Higgins JPT, Altman DG (2017) Chapter 9: Analysing data and undertaking meta- analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, eds. Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane

  • E9 Statistical Principles for Clinical Trials (1998) ICH Harmonised Tripartite Guideline CPMP/ICH/363/96

  • Freuding M, Keinki C, Micke O, Buentzel J, Huebner J (2019) Mistletoe in oncological treatment: a systematic review: part 1: survival and safety. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-018-02837-4

    Article  PubMed  Google Scholar 

  • Higgins JPT, Altman DG, Sterne JAC (2017) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, eds. Cochrane handbook for systematic reviews of interventions. 5.2.0 edn. Cochrane

  • Tröger W, Galun D, Reif M, Schumann A, Stankovic N, Milicevic M (2013) Viscum album L. extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 49:3788–3797

    Article  PubMed  Google Scholar 

  • Tröger W, Galun D, Reif M, Schumann A, Stankovic N, Milicevic M (2014) Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Deutsches Ärzteblatt Int 111:493–502

    Google Scholar 

  • Zänker KS, Kaveri SV (2015) Mistletoe: From mythology to evidence-based medicine. In: Chan SHH (ed) Translational research in biomedicine, vol 4. Karger, Berlin

    Google Scholar 

Download references

Acknowledgements

H. Matthes is a member of the guideline committee for integrative oncology. F. Schad received research grants from Abnoba, Helixor and Hiscia and R. Huber has been working in a scientific advisory board for Abnoba and received research grants from Abnoba, Helixor and Hiscia.

Author information

Authors and Affiliations

  1. Institute for Social Medicine, Epidemiology and Health Economics and Department of Gastroenterology, Infectiology and Rheumatology, Charité Universitätsmedizin Berlin, Charité CCM and CBF, Berlin, Germany

    H. Matthes

  2. Interdisciplinary Tumour Centre Mannheim, University Medicine of Mannheim, Mannheim, Germany

    R.-D. Hofheinz

  3. Emek Medical Center, Afula, Israel

    G. Bar-Sela

  4. Clinical Center of Serbia, Belgrade and Medical School, University of Belgrade, Belgrade, Serbia

    D. Galun

  5. Gerhard Kienle Chair for Medical Theory, Integrative and Anthroposophical Medicine, Department of Human Medicine, Faculty of Health, University of Witten/Herdecke, Witten/Herdecke, Germany

    D. Martin

  6. Center for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Freiburg, Germany

    R. Huber

  7. Clinic for Integrative Medicine and Naturopathy, Social Foundation Bamberg, Klinikum am Bruderwald, Bamberg, Germany

    J. Langhorts

  8. Institute for Integrative Medicine at the University of Witten/Herdecke, Witten/Herdecke, Germany

    P. F. Matthiessen

  9. Department of Oncology, Hospital Havelhöhe, Berlin, Germany

    F. Schad

Authors
  1. H. Matthes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R.-D. Hofheinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Bar-Sela
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Galun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Langhorts
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. F. Matthiessen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Schad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Matthes.

Ethics declarations

Conflict of interest

The authors R.-D. Hofheinz, G. Bar-Sela, D. Galun, D. Martin, J. Langhorst and P.F. Matthiessen declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matthes, H., Hofheinz, RD., Bar-Sela, G. et al. Letter to the editors of the Journal of Cancer Research and Clinical Oncology. J Cancer Res Clin Oncol 145, 2405–2407 (2019). https://doi.org/10.1007/s00432-019-02926-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-019-02926-y

Search

Navigation